CWG
LENZ

C WorldWide Group’s LENZ Therapeutics LENZ Stock Holding History

C WorldWide Group’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.98M Hold
700,000
– – 0.1% 68
2026
Q1 		$6.41M Buy
700,000
+200,000
+40% +$2.81M 0.14% 66
2025
Q4 		$8M Buy
+500,000
New +$14.6M 0.14% 67

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

C WorldWide Group's LENZ Position: Q2 2026 in Review

C WorldWide Group held its LENZ Therapeutics (LENZ) position steady in Q2 2026 at 700,000 shares worth $3.98M. The position accounts for 0.1% of the portfolio, ranked #68.

C WorldWide Group first reported a position in LENZ in Q4 2025 and has held it in 3 quarters since. The position peaked at $8M in Q4 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • C WorldWide Group held 700,000 shares of LENZ Therapeutics worth $3.98M as of Q2 2026.
  • C WorldWide Group left its LENZ Therapeutics share count unchanged in Q2 2026.
  • LENZ Therapeutics made up 0.1% of C WorldWide Group's portfolio in Q2 2026, its #68 holding.
  • C WorldWide Group first reported a position in LENZ Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • C WorldWide Group's LENZ Therapeutics position peaked at $8M in Q4 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on C WorldWide Group's 13F filing for Q2 2026, filed 4 Aug 2026.